Apricus Biosciences, Inc.
(NASDAQ : APRI)

( )
APRI After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Gold Updates?
Receive the latest updates on the gold and silver markets.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Other
symbolcompany%chnglast%shortavg$volume
VRXValeant Pharmaceuticals International, Inc.
0.49%14.4214.2%$227.85m
SHPGShire PLC Sponsored ADR
-0.22%142.840.4%$213.78m
PRGOPerrigo Co. Plc
-1.49%77.436.4%$150.76m
MNKMallinckrodt Plc
0.22%37.2017.7%$117.37m
UTHRUnited Therapeutics Corporation
-0.43%130.7213.9%$87.52m
JAZZJazz Pharmaceuticals Plc
-0.16%146.502.2%$80.04m
ENDPEndo International Plc
-0.48%8.348.9%$70.27m
HZNPHorizon Pharma plc
-1.45%12.937.6%$64.54m
ALRAlere Inc.
-0.35%49.392.7%$63.82m
PRXLPAREXEL International Corporation
-0.08%87.667.9%$62.65m
ICPTIntercept Pharmaceuticals, Inc.
-0.14%106.9422.1%$62.05m
MYOKMyoKardia, Inc.
0.80%44.153.0%$54.03m
MDCOMedicines Company
1.92%36.0922.3%$43.38m
PTLAPortola Pharmaceuticals, Inc.
0.59%56.288.9%$42.36m
ICLRICON Plc
-1.03%106.784.2%$41.60m

Company Profile

Apricus Biosciences, Inc. is a pharmaceutical company focus on the development and commercialization of products and product candidates in the areas of specialty urology and rheumatology. The company products include Vitaros and Femprox. It operates through Pharmaceutical segment which designs, and develops pharmaceutical products including those with its NexACT platform. Apricus Biosciences was founded in 1987 and is headquartered in San Diego, CA.